Search Results - "Manabu Fujimotoa"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Development of alopecia areata-like reactions in a patient treated with dupilumab by Saki Yamanea, Yukinobu Nakagawaa, Shigeki Inuib, c, Manabu Fujimotoa

    Published in Allergology International (01-07-2022)
    “…[Dear Editor, ] Dupilumab is a human monoclonal antibody approved for treating moderate-to-severe adult atopic dermatitis (AD) that suppresses the Th2 immune…”
    Get full text
    Journal Article
  2. 2

    Refractory dermatomyositis which developed in a patient with silicone breast implants by Yoko Imanakaa, Yukinobu Nakagawaa, Toshifumi Yamaokaa, Yorihisa Kotobukia, Misa Hayashia, Ichiro Katayamaa, Yuki Ichimurab, Naoko Okiyamab, Manabu Fujimotoa

    Published in Allergology International (01-01-2022)
    “…Dear Editor, Dermatomyositis (DM) is an idiopathic inflammatory disorder characterized by proximal muscle weakness and cutaneous manifestations, including…”
    Get full text
    Journal Article
  3. 3

    A case of zonisamide-induced toxic epidermal necrolysis with acute respiratory failure by Miki Kumea, Yukinobu Nakagawaa, Eiji Kiyoharaa, Noriko Arasea, Mari Wataya-Kanedaa, Moto Yagab, Masahiro Yanagawac, Manabu Fujimotoa

    Published in Allergology International (01-10-2020)
    “…Dear Editor, Toxic epidermal necrolysis (TEN) is a life-threatening cutaneous adverse drug reaction characterized by a high fever and widespread erosions of…”
    Get full text
    Journal Article